INNOCELL TECHNOLOGY CO., LTD.
Update：2026/08/14
Industries
Main Industry
Biotechnology
Main Product/Service
Immune Cell Processing and Exosome Purification Platform Technologies (iKNOBeads, iGDP, iCDV)
Founded Year
2025
Unified Business No.
95434189
Status
Active
Number of Employees
0
Total Paid-in
Capital
75,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Website
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
INNOCELL TECHNOLOGY is a spin-off startup from the Industrial Technology Research Institute (ITRI) that focuses on the development of key materials for immune cell processing and exosome processing platform technologies. The company’s core technologies include the biomimetic magnetic bead-based immune cell production platform (iKNOBeads), the non-viral nuclear delivery platform (iGDP), and the high-purity exosome production platform (iCDV). These technologies can be applied to the activation and expansion of immune cells, cell engineering, and exosome production development, helping to enhance the efficiency, stability, and scalability of cell and exosome production processes.
